Jyong Biotech income statement data for the quarter ended Dec 2025. This income statement covers 3 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 73.36M | 76.03M | |
| Additional items | |||
| Shares Outstanding | 71.57M | 71.57M | 73.01M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 71.57M | 71.57M | 73.01M |